Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

PURPOSE: We tested the hypothesis that allosteric Akt inhibitor MK-2206 inhibits tumor growth, and that PTEN/PIK3CA mutations confer MK-2206 sensitivity. EXPERIMENTAL DESIGN: MK-2206 effects on cell signaling were assessed in vitro and in vivo. Its antitumor efficacy was assessed in vitro in a panel...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Sangai, Takafumi, Akcakanat, Argun, Chen, Huiqin, Tarco, Emily, Wu, Yun, Do, Kim-Anh, Miller, Todd W., Arteaga, Carlos L., Mills, Gordon B., Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3772348/
https://ncbi.nlm.nih.gov/pubmed/22932669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1141
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items